Scientific Day 2021 | June 10

Corps éditorial

Epidemiology, medical research, innovation: a day to take stock of the advances underway thanks to Epicentre

Epicentre's Scientific Day is an opportunity to learn about current epidemiology and humanitarian research activities and projects. This year, the COVID-19 pandemic was the subject of a session as Epicentre has been working since the beginning to assess the situation in MSF intervention sites and in some regions of the African continent to evaluate the real incidence.

The day also provided an opportunity to review other diseases, including results on tuberculosis, antibiotic resistance, post-abortion complications, snake bites, the development of digital health innovations, and the possibilities offered by dose splitting to improve access to yellow fever vaccines.

Given the changing international healthcare landscape and the higher prevalence of chronic non-communicable diseases such as cancer, one session will be devoted to Epicentre's studies in the field of oncology, an area of MSF's developing operational policy. 

Epicentre makes every effort to provide information and practical solutions to improve access to quality healthcare for populations living in unstable conditions or insufficient access to care. This objective is based on our intangible link with MSF, our experience, and our team's expertise.

Review the presentations

Session 1 | COVID-19

Moderator : Mathieu Bichet, MSF, France

  • Epidemiological and medical characteristics of patients in MSF programs. Anaïs Broban | Read the abstract
  • Focus on  Yemen and Afghanistan. Amna Haider, Flavio Finger | Read the abstract
  • Clinical description and outcome of patients admitted in the MSF COVID-19 treatment center, Herat, Afghanistan. Elisabeth Poulet | Read the abstract
  • Preliminary results of SARS-COV-2 seroprevalence and retrospective mortality surveys in low-income countries (DRC, Kenya, Mali, Niger, Yemen). Etienne Gignoux | Read the abstract
  • Mortality and seroprevalence of SARS-CoV-2 among general population in Omduran – Sudan. Wendelin Moser

REVIEW THE PRESENTATIONS OF THE SESSION

File
Epidemiological and medical characteristics of patients in MSF programs
Anaïs Broban | JS2021
File
COVID19: Focus on Yemen
Amna Haider | JS2021
File
COVID19: Focus on Afghanistan.
Flavio Finger | JS2021
File
Clinical description and outcome of patients admitted in the MSF COVID-19 treatment center, Herat, Afghanistan.
Elisabeth Poulet | JS2021
File
Preliminary results of SARS-COV-2 seroprevalence and retrospective mortality surveys in low-income countries (DRC, Kenya, Mali, Niger, Yemen).
Etienne Gignoux | JS2021
File
Mortality and seroprevalence of SARS-CoV-2 among general population in Omduran – Sudan
Wendelin Moser | JS2021

Session 2 | Cancer

Moderator: Christopher Mambula, Médecins Sans Frontières, France 

  • Cancer, a new challenge for MSF: example of an oncology in project in Mali. Claire Rieux, Marie-Hortense Koudika | Read the abstract
  • Improved outcomes for Kaposi sarcoma using pegylated liposomal doxorubicin. Matthew Coldiron | Read the abstract
  • Cervical cancer prevention in Malawi: HPV vaccination and cervical pre-cancer screening coverage.Sibylle Gerstl,  Robin Nesbitt | Read the abstract

 

REVIEW THE PRESENTATIONS OF THE SESSION

File
Cancer, a new challenge for MSF: example in project in Mali
Claire Rieux & Marie-Hortense Koudika | JS 2021
File
Improved outcomes for Kaposi sarcoma using pegylated liposomal doxorubicin
Matthew Coldiron | JS2021
File
Cervical cancer prevention in Malawi: HPV vaccination and cervical pre-cancer screening coverage
Sibylle Gerstl, Robin Nesbitt | JS2021

Session 3 | Update on projects

Moderator: Anne-Laure Page, WHO, Switzerland 

  • Diagnostic performance and feasibility of FujiLAM to detect tuberculosis. Helena Huerga, Chenai Mathabire Rücker, Pascale Lissouba | Read the abstract
  • Practices and challenges related to antibiotic use in paediatrics in Niger and Uganda. Céline Langendorf | Read the abstract

REVIEW THE PRESENTATIONS OF THE SESSION

File
Diagnostic performance and feasibility of FujiLAM to detect tuberculosis
Helena Huerga, Chenai Mathabire Rücker, Pascale Lissouba | JS2021
File
Practices and challenges related to antibiotic use in paediatrics in Niger and Uganda
Céline Langendorf | JS2021

Session 4 | Digital Health Innovations

  • Contribution of (new) technologies in epidemiology. Anton Camacho | Read the abstract

REVIEW THE PRESENTATION OF THE SESSION

File
Contribution of (new) technologies in epidemiology
Anton Camacho | JS2021

​​​​​​​Session 5 | Neglected patients 

Moderator: Anne Bissek, Ministry of Health, Cameroon 

  • Evaluation of the Inoserp antivenom for snakebites in Cameroon. Fai Karl | Read the abstract
  • Validation of a clinical score for the diagnosis of Mycobacterium ulcerans (Buruli Ulcer) infection in Cameroon. Rodrigue Ntone | Read the abstract
  • Abortion-related complications and their clinical management in a referral hospital of a conflict-affected setting in Central African Republic. Estelle Pasquier | Read the abstract

REVIEW THE PRESENTATIONS OF THE SESSION

File
Evaluation of the Inoserp antivenom for snakebites in Cameroon
Fai Karl | JS2021
File
Validation of a clinical score for the diagnosis of Mycobacterium ulcerans (Buruli Ulcer) infection in Cameroon
Rodrigue Ntoné |JS2021
File
Abortion-related complications and their clinical management in a referral hospital of a conflict-affected setting in Central African Republic
Estelle Pasquier | JS2021

 Session 5 | Vaccination 

Moderator: Mamady Traoré, Médecins sans Frontières, France 

  • Fractional dosing of vaccines: when less could mean more. Aitana Juan | Read the abstract
  • Ebola vaccination: what's the problem? Natalie Roberts | Read the abstract
  • Effectiveness of conjugated typhoid fever vaccine, Harare, Zimbabwe. Maria Lightowler | Read the abstract

REVIEW THE PRESENTATIONS OF THE SESSION

File
Fractional dosing of vaccines: when less could mean more
Aïtana Juan | JS2021
File
Effectiveness of conjugated typhoid fever vaccine, Harare, Zimbabwe
Maria Lightowler | JS2021
File
Ebola vaccination: what's the problem?
Natalie Roberts | JS2021

Contact us

Résumé
Please use this form for additional information regarding the Scientific Day.
Référence
Civility

* Required fields

The information you provide is for the exclusive use of Epicentre and will only be used to respond to your request for information about the Scientific Day. For more information on how your personal data is processed and your rights (access, rectification, deletion, limitation, portability, opposition) please consult our privacy policy.
Learn more about the processing of your data and your rights.

Research Center Niger

Find out more
Coronavirus, Tribune Eboko, in the Journal Le Monde

Research Center Uganda

Find out more
Dan Nyehangane et son équipe dans le centre de Mbarara

Scientific Day 2020

Find out more
Photo slider JS 2020